Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Thymosin beta4 safe in phase II corneal wound-healing study

May 6, 2010

Combined GM-CSF and agatolimod arm melanoma sentinel lymph nodes against metastasis

May 6, 2010

Pan-CDK inhibitor BAY-1000394 exhibits favorable pharmacologic profile in preclinical evaluation

May 5, 2010

LiGluR gene therapy reinstates visual responses in inherited blindness models

May 5, 2010

Antioxidant activity of dextromethorphan may be beneficial in retinitis pigmentosa

May 5, 2010

Preclinical data on nucleolin-binding peptide EP-302 support further development in cancer therapy

May 5, 2010

Cullin-1 emerges as a potential biomarker for the early diagnosis of human melanoma

May 5, 2010

Novel CRAC inhibitor synthesized at Incozen Therapeutics

May 5, 2010

AG-011 ineffective in phase II ulcerative colitis study

May 4, 2010

Clinical study, meta-analysis reveal intraocular pressure reductions with PF-4217329

May 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...